RB1 and glioblastoma: Three signaling pathways are commonly deregulated in GBMs: loss of function of RB, loss of function of p53, and gain of function of RTK/RAS/PI3K.12 Furthermore, certain genetic alterations have been found helpful in differentiating primary and secondary GBM tumors.